Brief: Ipca Labs says U.S.FDA has not carried new inspections at co's Madhya Pradesh, Pithampur, Silvassa plants
20/06/2017 07:04
June 20 (Reuters) - Ipca Laboratories Ltd IPCA.NS :
* Says clarification on U.S. FDA communication on company's
manufacturing units
* USFDA clarified issuing letters is for withdrawal of
exemption on certain drugs which was due to change in drug
shortage situation in us
* Says fda has not carried any new inspection/reinspection
of its plants at Madhya Pradesh,Pithampur and Silvassa
Source text for Eikon: ID:nBSEbBLCs8
Further company coverage: IPCA.NS
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Ipca Laboratories
See all newsBrief: Ipca Labs March-Quarter Consol Net Profit 3 Billion Rupees
Brief: Ipca Labs Posts Dec-Qtr Consol Net PAT 3.26 Billion Rupees
Brief: IPCA Labs Says US FDA Issues Form 483 With Three Observations
Brief: IPCA Labs Sept-Quarter Consol Net Pat 2.83 Billion Rupees
Brief: IPCA Labs Says To Sell Unit In Ankleshwar For 221.5 Mln Rupees